{"filing":{"accession_number":"0001193125-26-430419","cik":"0001671584","ticker":"APVO","company_name":"Aptevo Therapeutics Inc.","form":"8-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"apvo-20261023.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526430419/apvo-20261023.htm"},"events":[{"id":37576,"run_id":34629,"accession_number":"0001193125-26-430419","anchor_item_number":"1.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"summary":"Aptevo Therapeutics amended its Rights Agreement (Amendment No. 6), extending the Final Expiration Date to October 23, 2027 and adjusting the Purchase Price to $14.56 per Preferred Share. The amendment modifies security holders' rights under the shareholder rights plan.","company_name":"Aptevo Therapeutics Inc.","ticker":"APVO","filing_date":"2026-10-23","form":"8-K","submitted_at":null,"items":[{"id":42334,"accession_number":"0001193125-26-430419","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"This disclosure concerns Amendment No. 6 to a Rights Agreement (a shareholder rights plan or \"poison pill\"), which extends the Final Expiration Date to October 23, 2027 and adjusts the Purchase Price to $14.56 per Preferred Share. Rights plan amendments are governance matters, but this is a routine administrative extension and price adjustment rather than a material change in control dynamics or shareholder protections. The amendment does not signal a triggering event, acquisition threat, or material change in the company's governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:07:47.715371+00:00","company_name":"","ticker":null,"filing_date":""},{"id":42335,"accession_number":"0001193125-26-430419","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"Item 3.03 discloses a material modification to security holders' rights by incorporating Item 1.01 (Entry into a Material Definitive Agreement). Without the full text of Item 1.01, the specific nature of the modification cannot be determined, but the cross-reference indicates a governance-related change affecting shareholder rights. This is classified as governance_other because the domain is clearly governance (security holder rights) but the specific event type cannot be determined from the excerpt alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:07:47.715371+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42334,"accession_number":"0001193125-26-430419","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"This disclosure concerns Amendment No. 6 to a Rights Agreement (a shareholder rights plan or \"poison pill\"), which extends the Final Expiration Date to October 23, 2027 and adjusts the Purchase Price to $14.56 per Preferred Share. Rights plan amendments are governance matters, but this is a routine administrative extension and price adjustment rather than a material change in control dynamics or shareholder protections. The amendment does not signal a triggering event, acquisition threat, or material change in the company's governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:07:47.715371+00:00","company_name":"Aptevo Therapeutics Inc.","ticker":"APVO","filing_date":"2026-10-23"},{"id":42335,"accession_number":"0001193125-26-430419","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"Item 3.03 discloses a material modification to security holders' rights by incorporating Item 1.01 (Entry into a Material Definitive Agreement). Without the full text of Item 1.01, the specific nature of the modification cannot be determined, but the cross-reference indicates a governance-related change affecting shareholder rights. This is classified as governance_other because the domain is clearly governance (security holder rights) but the specific event type cannot be determined from the excerpt alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:07:47.715371+00:00","company_name":"Aptevo Therapeutics Inc.","ticker":"APVO","filing_date":"2026-10-23"}]}